文献速递瓣膜病与结构性心脏病心力衰竭与心肌病

三尖瓣:病理、影像与当前治疗选择的科学声明

The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.
PubMed 文献 · Circulation · 2024-04-25

美国心脏协会科学声明指出三尖瓣疾病常被低估且与显著病残率和死亡率相关,患者常晚期就诊并伴严重右心衰、肺动脉高压和难治症状。声明强调三尖瓣解剖复杂且毗邻右冠状动脉和房室结,病理机制分原发、继发或混合,需多种先进影像评估以选择经导管治疗并考虑终身管理。

要点

  • 三尖瓣疾病常被低估,与显著病残率和死亡率相关,患者常晚期就诊。
  • 三尖瓣解剖复杂,毗邻右冠状动脉和房室结,且为起搏导线通道。
  • 病理机制分原发、继发或混合,无单一器械适合所有病例。

核心结论

  • 三尖瓣疾病是常被低估的临床问题,与显著病残率和死亡率相关,患者常晚期出现严重右心衰和肺动脉高压。
  • 经导管三尖瓣治疗近年兴趣增加并取得成功,为既往治疗选择有限的患者提供新选择。

研究设计与样本

  • 美国心脏协会科学声明,综述三尖瓣疾病的背景、解剖考虑、治疗选择和未来方向。

主要发现

  • 三尖瓣解剖复杂,毗邻右冠状动脉和房室结,且是永久起搏导线进入右心室的通道。
  • 三尖瓣病理机制因患者而异,可为原发、继发或混合原因,无单一器械适合所有病例。
  • 先进心脏影像包括经胸超声心动图、经食管超声心动图、心脏计算机断层扫描和心脏磁共振成像,常需多种模态以最佳显示病理。

临床怎么用

  • 详细影像提供重要信息以选择理想经导管治疗选项,并考虑患者终身管理需求。
  • 传统治疗仅药物或手术,经导管治疗为既往选择有限的患者提供新选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tricuspid valve disease is an often underrecognized clinical problem that is associated with significant morbidity and mortality. Unfortunately, patients will often present late in their disease course with severe right-sided heart failure, pulmonary hypertension, and life-limiting symptoms that have few durable treatment options. Traditionally, the only treatment for tricuspid valve disease has been medical therapy or surgery; however, there have been increasing interest and success with the use of transcatheter tricuspid valve therapies over the past several years to treat patients with previously limited therapeutic options. The tricuspid valve is complex anatomically, lying adjacent to important anatomic structures such as the right coronary artery and the atrioventricular node, and is the passageway for permanent pacemaker leads into the right ventricle. In addition, the mechanism of tricuspid pathology varies widely between patients, which can be due to primary, secondary, or a combination of causes, meaning that it is not possible for 1 type of device to be suitable for treatment of all cases of tricuspid valve disease. To best visualize the pathology, several modalities of advanced cardiac imaging are often required, including transthoracic echocardiography, transesophageal echocardiography, cardiac computed tomography, and cardiac magnetic resonance imaging, to best visualize the pathology. This detailed imaging provides important information for choosing the ideal transcatheter treatment options for patients with tricuspid valve disease, taking into account the need for the lifetime management of the patient. This review highlights the important background, anatomic considerations, therapeutic options, and future directions with regard to treatment of tricuspid valve disease.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Davidson LJ, Tang GHL, Ho EC, et al. The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association. Circulation. 2024. PMID: 38660790. doi:10.1161/CIR.0000000000001232

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。